Dermatan sulphate is an activating ligand of anaplastic lymphoma kinase
Dermatan sulphate is an activating ligand of anaplastic lymphoma kinase
复制标题
硫酸皮肤素是间变性淋巴瘤激酶的激活配体
DOI:
10.1093/jb/mvab085
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Sakamoto Kazuma
中科院分区:
文献类型:
--
作者:
Machino Masaaki;Gong Yuanhao;Ozaki Tomoya;Suzuki Yuji;Watanabe Eri;Imagama Shiro;Kadomatsu Kenji;Sakamoto Kazuma
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) that harbours a tyrosine kinase domain in its intracellular region and is expressed in both central and peripheral nervous systems. RTKs are activated upon ligand binding and receptor clustering; however, ALK remains an orphan receptor despite its pathological significance, especially in malignancy. Recent biochemical work showed that heparan sulphate (HS), an unbranched sulphated glycan, acts as a ligand for and activates ALK. Here, we show that dermatan sulphate (DS, chondroitin sulphate B) directly interacts with the extracellular N-terminal region of ALK as well as HS. The tetrasaccharide of DS was required and was sufficient for inducing autophosphorylation of ALK at tyrosine 1604, a marker for activated ALK. Interestingly, longer oligosaccharides caused enhanced activation of ALK, as was the case for HS. Our results provide a novel example of glycans as signalling molecules and shed light on the pathophysiological roles of ALK.